Table of Contents

company-logo

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

Rani Therapeutics Dividend Announcement

• Rani Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Rani Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Rani Therapeutics Dividend History

Rani Therapeutics Dividend Yield

Rani Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Rani Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Rani Therapeutics Financial Ratios

P/E ratio-2.26
PEG ratio-0.24
P/B ratio24.33
ROE-300.92%
Payout ratio0.00%
Current ratio1.93
Quick ratio1.93
Cash Ratio0.30

Rani Therapeutics Dividend FAQ

Does Rani Therapeutics stock pay dividends?
Rani Therapeutics does not currently pay dividends to its shareholders.
Has Rani Therapeutics ever paid a dividend?
No, Rani Therapeutics has no a history of paying dividends to its shareholders. Rani Therapeutics is not known for its dividend payments.
Why doesn't Rani Therapeutics pay dividends?
There are several potential reasons why Rani Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Rani Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Rani Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Rani Therapeutics a dividend aristocrat?
Rani Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Rani Therapeutics a dividend king?
Rani Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Rani Therapeutics a dividend stock?
No, Rani Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Rani Therapeutics stocks?
To buy Rani Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Rani Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.